NCT06476808Not yet recruitingPhase 1
Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors
Source: EU CTIS (euclinicaltrials.eu) · Last updated 18 Sept 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 17 Apr 2026
- Start date
- 1 Aug 2026
- Lead sponsor
- Bristol-Myers Squibb Services Unlimited Company
- Diseases
- Lung cancer, Ovarian cancer
- NCT number
- NCT06476808
- EU CT number
- 2025-523067-38-01
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 20
- 8 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Not yet recruiting |
| Clinica Universidad de Navarra Coordinator of this site? Confirm its status | Madrid | Spain | Not yet recruiting |
| Clínica Universidad de navarra Coordinator of this site? Confirm its status | Pamplona | Spain | Not yet recruiting |
| Institut Bergonie Coordinator of this site? Confirm its status | Bordeaux | France | Not yet recruiting |
| Centre De Recherche En Cancerologie De Lyon Coordinator of this site? Confirm its status | Lyon | France | Not yet recruiting |
| Institut Gustave Roussy Coordinator of this site? Confirm its status | Villejuif Cedex | France | Not yet recruiting |
| Istituto Europeo di Oncologia s.r.l Coordinator of this site? Confirm its status | Milan | Italy | Not yet recruiting |
| Humanitas Mirasole S.p.A. Coordinator of this site? Confirm its status | Milan | Italy | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.